# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 2566 results.
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
Status: Completed
Last Changed: Oct 15, 2014
First Received: Mar 12, 2013
Disease(s): Recurrent Ovarian Cancer
Intervention(s): chemotherapy with doxorubicin and cisplatin
Locations: Ruhr University Bochum, Bochum, NRW, Germany
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Terminated
Last Changed: Jan 14, 2020
First Received: May 10, 2017
Disease(s): Ovarian Cancer
Intervention(s): NUC-1031 500 mg, NUC-1031 750mg
Locations: Arizona Oncology Associates, PC - HAL, Scottsdale, Arizona, United States
Arizona Oncology Associates, PC - HOPE, Tucson, Arizona, United States
University of California, Orange, California, United States
Rocky Mountain Cancer Centers, LLP, Lakewood, Colorado, United States
Florida Cancer Affiliates - Ocala, Ocala, Florida, United States
... and 18 other locations.
Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer
Status: Recruiting
Last Changed: Nov 13, 2017
First Received: Nov 07, 2017
Disease(s): Ovarian Cancer
Intervention(s): Fludarabine and Pegylated liposomal doxorubicin, Pegylated liposomal doxorubicin
Locations: Sun Yat-sen University Cancer, Guangzhou, Guangdong, China
Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer
Status: Not yet recruiting
Last Changed: Aug 28, 2019
First Received: Aug 28, 2019
Disease(s): Recurrent Platinum-resistant Ovarian Cancer
Intervention(s): Camrelizumab (SHR-1210), Apatinib
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Status: Completed
Last Changed: Jul 24, 2018
First Received: Mar 23, 2009
Disease(s): Ovarian Cancer
Intervention(s): Bendamustine HCL
Locations: Arizona Cancer Center, Tucson, Arizona, United States
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Status: Terminated
Last Changed: Dec 15, 2009
First Received: Apr 24, 2006
Disease(s): Ovarian Cancer
Intervention(s): lapatinib
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Indiana University School of Medicine, Indianapolis, Indiana, United States
Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Status: Recruiting
Last Changed: Aug 25, 2016
First Received: Aug 25, 2016
Disease(s): Ovarian Cancer
Intervention(s): Cancer treatment
Locations: LAVOUE, Rennes, France
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
Status: Completed
Last Changed: Dec 22, 2014
First Received: Oct 20, 2006
Disease(s): Ovarian Cancer
Intervention(s): Sorafenib, Paclitaxel, Carboplatin
Locations: Northeast Arkansas Clinic, Jonesboro, Arkansas, United States
Florida Cancer Specialists, Fort Myers, Florida, United States
Holy Cross Hospital, Ft. Lauderdale, Florida, United States
Gulfcoast Oncology Associates, St. Petersburg, Florida, United States
Medical College of Georgia Cancer Specialists, Augusta, Georgia, United States
... and 13 other locations.
Trial in Patients With Relapsed Ovarian Cancer
Status: Recruiting
Last Changed: Oct 31, 2019
First Received: Aug 30, 2017
Disease(s): Ovarian Cancer
Intervention(s): Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562
Locations: VejleSygehus, Vejle, Region Syddanmark, Denmark
Rigshospitalet, København Ø, Sjaelland, Denmark
Tampere University Hospital, Tampere, Finland
Haukeland University Hospital, Bergen, Haukeland, Norway
The Norwegian Radium Hospital, Oslo, Norway
... and 1 other locations.
NYU Ovarian Cancer Early Detection Program Blood and Genetics
Status: Terminated
Last Changed: Jan 11, 2011
First Received: Sep 19, 2007
Disease(s): Ovarian Cancer
Locations: NYUCancer Institute Clinical Cancer Center, New York, New York, United States